Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$152,767
-$36,529 QoQ
Shares Held
245
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,069
of 1,322 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SYNTAX RESEARCH, INC. holds $153,107 across 2 Biotechnology names. REGN ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
245 | $152,767 | |
| 2 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
142 | $340 |
All Filings in REGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,767 | 245 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $189,296 | 245 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $189,108 | 245 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $137,756 | 245 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $128,625 | 245 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $155,386 | 245 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $174,520 | 245 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $257,553 | 245 | Shares | Sole | 2024-12-18 | |
| 2024-06-30 | $362,605 | 345 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $332,059 | 345 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $303,010 | 345 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $283,921 | 345 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||